Status:
UNKNOWN
The Effects of Inspiratory Muscle Training on Endurance Performance in Trained Athletes Under Normoxic and Hypoxic Conditions: A Gender-based Comprehensive Study
Lead Sponsor:
University of Lausanne
Conditions:
Hypoxia, Altitude
Eligibility:
All Genders
18-44 years
Phase:
NA
Brief Summary
The POWERbreathe™ Plus: an Inspiratory Muscle Training device (IMT) with adjustable resistance. Intervention lasts 4 weeks, with a frequency of 6 days/week, 2 series of 30 inspirations in the morning...
Detailed Description
The POWERbreathe™ Plus: an Inspiratory Muscle Training device (IMT) with adjustable resistance. Intervention lasts 4 weeks, with a frequency of 6 days/week, 2 series of 30 inspirations in the morning...
Eligibility Criteria
Inclusion
- Inclusion: endurance trained athletes between 18 and 44 years old
Exclusion
- cardiovascular, metabolic and respiratory diseases, smoking history, prescription medication (Two medication families are known to interfere with FC:
- Calcium channel blockers
- Beta-blockers
- Two families are known to interfere during spirometry measurements:
- Inhaled beta-agonists
- Inhaled glucocorticoids)
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06121128
Start Date
December 1 2023
End Date
August 31 2024
Last Update
November 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.